知识产权

获取这些结果的RSS提要

此分类的故事和材料

文章
2 July 2013
+ English - 隐藏

作者: Middlesex University (UK)

The objective of this course is to provide participants with an understanding of the legal basis underpinning the creation of human rights standards and organs through the prism of topics considered a priority on the international human rights agenda...

了解更多

文章
19 June 2013
+ English - 隐藏

作者: Lydie Pierre-Louis, David Orozco & Kevin J. McGarry

This article will examine the nexus between human rights; knowledge produced, maintained, and regulated by indigenous societies; and equitable principles inherent within private contract law. The issue of indigenous knowledge has generated significant...

了解更多

文章
14 June 2013
+ English - 隐藏

作者: Henry Zakumumpa, in The Independent (Uganda)

The lives of thousands of Ugandans enrolled on HIV treatment hang in the balance after an application by poor countries to extend the deadline for manufacture of generic AIDS drugs was rejected by the World Trade Organization (WTO)...Over 90% of HIV...

了解更多

文章
13 June 2013
+ English - 隐藏

作者: Megan McGrath, Voice of America

Everyone has BRCA genes in their cells. If you are a woman and one of your BRCA gene copies has a mutation, your risk of developing breast cancer is very high - up to 87 percent in some cases…Myriad Genetics Inc. was the first to discover the healthy,...

了解更多

文章
13 June 2013
+ English - 隐藏

作者: Intellectual Property Watch

The United Nations Human Rights Council today adopted a resolution urging governments to encourage technology development and transfer and to apply intellectual property rights measures in ways that avoid creating barriers to trade in “affordable, safe...

了解更多

文章
14 May 2013
+ English - 隐藏

作者: Tim Smedley, Guardian [UK]

On 1 April, pharma giant Novartis lost a six-year legal battle after the Indian supreme court ruled that small changes to its leukaemia drug Glivec did not deserve a new patent.…And only one month before, India upheld a compulsory licence of Bayer's...

了解更多

文章
29 April 2013
+ English - 隐藏

作者: Arvind Subramanian, Asian Scientist (Singapore)

...[T]he Indian Supreme Court dismissed the attempt by Novartis...to obtain patent protection for...Glivec...The verdict follows the Indian Patent Office’s decision last month to grant an Indian drug manufacturer a compulsory licence to sell a generic...

了解更多

文章
15 April 2013
+ English - 隐藏

作者: Achal Prabhala & Sudhir Krishnaswamy, in Hindu (India)

[T]he Supreme Court upheld the Intellectual Property Appellate Board’s decision to deny patent protection to Novartis’s application…[T]he…judgment effectively recast Indian patent law as being nuanced and original…[T]he global gold rush for patents has...

了解更多

文章
8 April 2013
+ English - 隐藏

作者: Joseph E. Stiglitz & Arjun Jayadev, Project Syndicate

The Indian Supreme Court’s refusal to uphold the patent on Gleevec, the blockbuster cancer drug developed by the Swiss pharmaceutical giant Novartis, is good news for many of those in India suffering from cancer. If other developing countries follow...

了解更多

文章
3 April 2013
+ English - 隐藏

作者: Lisa Shuchman, Corporate Counsel [USA]

When India's Supreme Court ruled this week that Novartis AG's cancer drug Gleevec was not sufficiently innovative to merit a patent, public health advocates lauded the decision, which they said would give more people access to needed drugs, and Big...

了解更多